Literature DB >> 30090843

Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration.

James Robert Brašić1, Zoltan Mari2, Alicja Lerner3, Vanessa Raymont1, Eram Zaidi1, Dean F Wong1.   

Abstract

Heat has been reported to exert variable effects on people with Gilles de la Tourette syndrome (TS). At age 24 years, a 32-year-old right-handed man with TS experienced a marked reduction in tics for two years after undergoing dehydration by entering a hot tub at 103°F (39.4°C) to 104°F (40.0°C) for 3 to 4 hours. On the Yale Global Tic Severity Scale (YGTSS) he scored 55 seven months before dehydration and 13 one month after dehydration. An intense heat exposure and dehydration led to an apparent remission in tics. The remission continued without the use of prescribed or nonprescribed medications or substances for two years until tics returned in the worst ever exacerbation after a tetanus immunization. The heat exposure may have altered at least temporarily his thermostat for normal heat-loss mechanisms through dopaminergic pathways from the anterior hypothalamus to the basal ganglia and the substantia nigra. Whether or not that mechanism or some other mechanism relevant to the heat exposure and/or dehydration is at play, the sudden and marked improvement in his tics needs further attention. Prospective testing of the heat and dehydration effect on tics should be pursued.

Entities:  

Keywords:  Basal ganglia; Dopamine; Hypothalamus; Substantia nigra; Thermoregulation; Thermostat; Tics

Year:  2018        PMID: 30090843      PMCID: PMC6078428          DOI: 10.4172/2329-9096.1000472

Source DB:  PubMed          Journal:  Int J Phys Med Rehabil        ISSN: 2329-9096


Introduction

Anecdotal reports of Gilles de la Tourette syndrome (TS) have suggested either improvement or worsening with heat [1]. Gilles de la Tourette himself reported that acute fever alleviated tics [1,2]. On the other hand, five of ten adult men with TS demonstrated prominent worsening of tics when the ambient temperature was increased from 22°C (71.6°F) to 35°C (95.0°F) [3]. Similarly, some people with autism, another developmental disability, demonstrate improvement of stereotypies and other movements with high temperature [4]. Reports on heat’s effect on tics and stereotypies vary between improvement [1,2] and worsening [3] without reaching a clear consensus. People with TS typically experience a decrement in tics with dopamine-receptor blocking drugs and an increment in tics from stimulants [1,3]. Release of dopamine in the preoptic area and the anterior hypothalamus plays a role in thermoregulation [3]. Although circuits for heat regulation may not overlap the circuits generating tics in TS, there may be indirect relationships between these circuits. Thus, the release of dopamine may play a role in mediating the effects of heat on tic intensity in people with TS [3]. There have been mixed reports on the rate of spontaneous remission in TS, as defined by greater than 10-point improvement the total score for tics (0-50) including both motor tics (0-25) and phonic tics (0-25) on the Yale Global Tic Severity Scale (YGTSS) [5]. Some investigators found a remission rate as low as 2/31 [6], while others reported somewhat higher rates [7-11]. When observed, spontaneous remission tends to occur at ages younger than the twenties, in patients who had shorter duration of illness, and with overall lower severity scores [12]. Based on the available literature on spontaneous remission, our patient, with moderately severe, long-standing TS in his mid-twenties, represents an exceedingly low probability for spontaneous remission.

Case Report

A young man participated in multiple assessments during research studies approved by the Institutional Review Board of the Johns Hopkins University School of Medicine, Baltimore, Maryland. He reported that he had induced dehydration several days after the episode without the consent or approval of the study physicians.

Clinical history

Since the age of 7 years, he experienced motor tics, including eye blinking, grimacing, and movements of head, shoulders, and fingers, and phonic tics, including grunting, snorting, and sniffing. Tics were exacerbated by cold, fatigue, and anxiety. Tics waxed and waned. Since childhood he experienced multiple tics simultaneously such as turning head to his shoulder along with a shoulder shrug. Since the age of 10 years, he experienced recurrent episodes of 2 to 3 months of daily emesis occurring intermittently throughout the year alternating with complete resolution of the emesis for 2 to 3 months. Each episode of emesis was preceded by an uncontrollable sensation in his throat, a short premonitory awareness of a feeling that the food is going to regurgitate. The emesis occurred only when eating solid foods. Emesis fluid never contained bile or stomach contents. He experienced a sore throat when he had emesis. Emesis occurred after one or two bites of food or midway through each meal. He successfully resumed eating after completing the emesis. Antacids did not relieve the emesis. He undertook diets with foods of various textures without beneficial effects. The symptoms occurred only during eating. He had no other swallowing difficulty, no nausea, no abdominal pain, and no odynophagia. He was unable to carry parcels with bottles for fear that they could be damaged if he experienced tics. At age 22, trials of clonidine and topiramate produced minimal effect on tics. At age 23, he began to occasionally smoke marijuana with relief of tics for 3 to 4 days. At age 23 years, 5 months, he had his baseline evaluation. For the baseline evaluation please refer to Table 1 for objective assessments.
Table 1:

Objective assessments of a 25-year-old man 7 months before and 1 and 11 months after an almost full remission following dehydration in a hot tub at 103°F (39.4°C) to 104°F (40.0°C) for 3 to 4 hours.

InstrumentRange of scoresSix months before remissionOne month after remissionEleven months after remission
Urine drug toxicology for tetrahydrocannabisNegative or positiveNegativePositivePositive
Abnormal Involuntary Movement Scale (AIMS) [13-15](0,40)901
Clinical Global Impression (CGI) Severity Index (SI) [16](0,7)4 Moderately mentally ill3 Mildly ill2 Borderline mentally ill
Clinical Global Impression (CGI) Global Improvement (GI) [16](0,7)4 No change2 Much improved1 Very much improved
Clinical Global Impression (CGI) Efficacy Index (EI) [16](0,16)13513
Clinical Global Impression (CGI) Therapeutic effect [16]Not applicableUnchanged or worseModerateUnchanged or worse
Clinical Global Impression (CGI) Side effects [16]Not applicableNoneNoneNone
Clinical Global Impression (CGI) Attention Deficit Disorder (ADD) [17](0,6)1 Borderline01 Borderline
Clinical Global Impression (CGI) Obsessive-Compulsive Disorder (OCD) [17](0,6)3 Moderate22 Mild
Clinical Global Impression (CGI) Tourette syndrome (TS) [17](0,6)3 Moderate11 Borderline
Clinical Global Improvement (CGI) Rater Global Evaluation (RGE) [18](1,7)4 Unchanged2 Much improved1 Very much improved
Hillside Akathisia Scale (HAS) Subjective items [13,19](0,8)000
Hillside Akathisia Scale (HAS) Objective items [13,19](0,12)600
Hillside Akathisia Scale (HAS) Clinical Global Impression (CGI) Severity of Akathisia (SA) [13,19](0,7)3 Mildly akathisic1 Normal, not akathisic1 Normal, not akathisic
Hillside Akathisia Scale (HAS) Clinical Global Impression (CGI) Global Improvement (GI) [13,19](0,7)4 No change1 Very much improved1 Very much improved
Magnetic resonance imaging of the brain [20, Table II, page 346]Normal or abnormalNormalNormalNormal
Maryland Psychiatric Research Center (MPRC) Brief Psychiatric Rating Scale (BPRS) Anchors [21-23](20,140)262121
Movement Disorders Checklist [14](0,23)1480
Myoclonus versus tic checklist [24](−2,6)630
National Institutes of Mental Health (NIMH) Obsessive-Compulsive Scale (OCS) [18](0,15)521
Rating Scale for Acute Drug-Induced Akathisia (RSADIA) Subjective [25](0,9)000
Rating Scale for Acute Drug-Induced Akathisia (RSADIA) Objective [25](0,21)100
Rating Scale for Acute Drug-Induced Akathisia (RSADIA) Global Rating [25](0,3)000
Rating scale for drug-induced akathisia (RSDIA) Subjective [26](0,6)000
Rating scale for drug-induced akathisia (RSDIA) Objective [26](0,3)100
Rating scale for drug-induced akathisia (RSDIA) Global Clinical Assessment of Akathisia (GCAA) [26](0,5)100
Rating Scale for Tardive Dyskinesia (RSTD) Face [27](16,96)261718
Rating Scale for Tardive Dyskinesia (RSTD) Neck and trunk [27](8,48)1188
Rating Scale for Tardive Dyskinesia (RSTD) Extremities (upper) [27](8,48)1188
Rating Scale for Tardive Dyskinesia (RSTD) Extremities (lower) [27](8,48)888
Rating Scale for Tardive Dyskinesia (RSTD) Entire body [27](4,24)444
Timed Stereotypies Rating Scale [14,28](0,1000)2721
Tourette Syndrome Diagnostic Confidence Index (TSDCI) [29](0,100)61Missing82
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [30.31](0,40)4104
Obsessive-Compulsive Disorder through the application of the criteria current at the time of the study [32] to the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [30,31]a(0,1)010
Yale Global Tic Severity Scale (YGTSS) Motor [5](0,25)191312
Yale Global Tic Severity Scale (YGTSS) Phonic [5](0,25)9011
Yale Global Tic Severity Scale (YGTSS) Impairment [5](0,50)2709

Obsessive-Compulsive Disorder (OCD) is diagnosed [32] if on the Y-BOCS [30,31] a person scores 2, 3, or 4 on any of the following items: 1 time spent on obsessions, or 2 interference from obsessions, or 3 distress of obsessions, or 6 time spent on compulsions, or 7 interference from compulsions, or 8 distress of compulsions

Family history

His mother has TS. His sister has obsessive-compulsive disorder. He is married with one child. At age 3 and a half years, his 5-year-old son began to display motor tics, including eye blinks and simultaneous head movements to the shoulder along with shoulder shrugs, and a phonic tic, exaggerated coughing, similar to the proband.

Other histories

His past medical, surgical, social, developmental, and family histories and his review of symptoms were otherwise noncontributory.

Clinical course

At the age of 24 years and one month, he deliberately induced dehydration by entering a hot tub of 103°F for 3 and a half hour. During the last one and a half hour in the tub, he noticed that his tics had subsided. He reported that his tics had not recurred. After leaving the hot tub, he vomited clear fluid. He drank water because he was thirsty. He then regurgitated the fluid. After leaving the tub he experienced cramps in his legs, arms, and neck. For two days after leaving the hot tub, his urine was pinkish orange. He felt weak for a couple of days after leaving the hot tub. A month after the dehydration, he scored 13 for motor tics, 0 for phonic tics, and 0 for impairment on the YGTSS [5]. Please refer to Table 1 for a record of the multiple assessments to document his improvement. He was able to work full time as a computer technician. He remained almost completely free of tics for 2 years after heat-induced dehydration. During this remission he denied the use of medications and substances without a prescription. Please refer to supplementary materials for video segments before and after his dehydration. At the age of 27, he experienced the worst ever acute exacerbation of all tics for two weeks after a tetanus immunization. The tics gradually returned to a mild level. He did not use medications or cannabis. At the age of 29, he began using Δ9-tetrahydrocannabinol (THC) as an inhaled vaper nightly. His tics remain at a mild level. He has emesis approximately every six months. He has no exacerbation of tics with cold. He works ten hour a day for two jobs. He readily carries stock including eggs to shelves for a job without problems.

Discussion

At age 25, a young man with TS experienced an almost full remission of symptoms sustained for 18 months after undergoing a presumptive dehydration in a hot tub at 103°F (39.4°C) to 104°F (40°C) for 3 to 4 hours. Cerebral hyperthermia results in an increased blood flow to the brain [33]. Heat exhaustion is a moderate illness resulting from depletion of water and salt associated with core body temperatures between 37°C and 40°C [34]. Heat produced alterations in both excitatory neurotransmitters, aspartate and glutamate, and inhibitory neurotransmitters, gamma-amino-butyric acid (GABA) and glycine [35]. Since dysfunction of the GABA-ergic system is a major effect of heat on the nervous system, the reduced inhibition resulting from damage to GABA neurotransmission may result in increased excitatory neurotransmission in response to heat [35]. Increased excitatory neurotransmission may stimulate further dopaminergic neurotransmission and may predispose a person to develop seizures [35]. Sustained excitatory neurotransmission may have produced a marked phasic increase in dopamine in our patient to result in a lasting effect on thermoregulation by the dopaminergic pathways from the anterior hypothalamus to the basal ganglia and the substantia nigra. Heat and/or dehydration may have led to tiny infarcts in our patient’s dopaminergic pathways from the anterior hypothalamus to the basal ganglia and the substantia nigra. The hyperthermia experienced by this man may have reset his thermostat for normal heat-loss mechanisms through dopaminergic pathways from the anterior hypothalamus to the basal ganglia and the substantia nigra. Whether or not that mechanism or some other mechanism relevant to the heat exposure and/or dehydration is at play, the sudden and marked improvement in his tics needs further attention. Prospective testing of the heat and dehydration effect on tics should be pursued. Clinical trials of dehydration and heat on TS may prove beneficial. The patient has been informed that unsupervised self-induced dehydration may result in serious morbidity and mortality; he has not repeated dehydration. The patient has noted beneficial effects of tetrahydrocannabinol (THC). He daily utilizes an inhaled vapor of THC nightly. THC, an antagonist of the cannabinoid receptor, has been utilized as a treatment for a spectrum of neuropsychiatric disorders [36]. While acute administration of THC produces increased dopamine release, chronic use reduces dopaminergic neurotransmission [37]. The interactions of THC with the dopaminergic system are complex, and not completely elucidated, however few modes of interactions described result in decreased activity of the dopaminergic system such as: 1) in humans chronic cannabis intake reduces dopamine synthesis capacity in the striatum as seen in a positron emission tomography (PET) study with 18-F-DOPA [38], 2) dopamine release is blunted in chronic human cannabis users [39], and 3) dopamine transporter (DAT) density is reduced in chronic cannabis users as seen in the PET study with 11-C PE2I, a selective DAT radioligand [40]. Because it was postulated that hypersensitivity of dopamine receptors and/or hyperactivity of dopaminergic neurons underlay the pathophysiology of Tourette syndrome [41,42], decrease of dopaminergic tone due to THC effects might have beneficial effects on tics severity. A randomized, double-blind, placebo-controlled crossover single-dose trial of THC in 12 patients with TS demonstrated significant improvements of tics and obsessive-compulsive behaviors [43]. A randomized, double-blind, placebo-controlled clinical trial of THC in 24 patients with TS demonstrated a significant reduction in tics with THC [44]. Nevertheless, systematic reviews concluded that the evidence is insufficient to support the use of THC and other cannabinoids to treat tics and obsessive-compulsive behaviors in people with TS [45,46]. Clinical trials with of THC for TS incorporating monitoring of dopaminergic and cannabinoid neurotransmission are needed to determine if THC is effective for TS. This case also illustrates retching and vomiting, rare manifestations of tics in TS [47,48].

Limitations

A placebo effect cannot be excluded in this open label exposure. Although the patient repeatedly exhibited normal temperatures during his baseline evaluation six months before his remission, we lack measured temperatures after the exposure to the hot bath. Given the relatively common occurrence of spontaneous remission, one could make an argument that association between two relatively common occurrences, heat exposure and remission of TS may be somewhat difficult to establish, given the high likelihood of co-occurrence by simple chance. Although he denied recent use of marijuana at each assessment, he may have experienced an effect of prior use of cannabis and related agents containing tetrahydrocannabinol [49]. Nevertheless, the occurrence of heat exposure and remission of TS may be chance. Spontaneous remissions of TS typically occur in adolescence. This patient is older than the typical adolescent to undergo a remission of TS. This single case report does not establish a causal sequence between heat-induced dehydration and remission of TS. Video 1. Segment 1: A 24-year-old man is asked to stand still for 2 minutes. He exhibits many tics of his eyes, face, neck, and hands. Video 1. Segment 2: Eighteen months later the 25-year-old man is asked to stand still for 2 minutes. This clip was taken 11 months after he apparently experienced dehydration by entering a hot tub at 103°F (39.4°C)-104°F (40.0°F) for 3 to 4 hours. Adventitious movements are minimal at this time.
  38 in total

Review 1.  Tic disorders: new developments in Tourette syndrome and related disorders.

Authors:  M M Robertson; J S Stern
Journal:  Curr Opin Neurol       Date:  1998-08       Impact factor: 5.710

2.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

3.  The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia.

Authors:  W W Fleischhacker; K J Bergmann; R Perovich; L K Pestreich; M Borenstein; J A Lieberman; J M Kane
Journal:  Psychopharmacol Bull       Date:  1989

4.  A rating scale for drug-induced akathisia.

Authors:  T R Barnes
Journal:  Br J Psychiatry       Date:  1989-05       Impact factor: 9.319

Review 5.  The effects of Δ9-tetrahydrocannabinol on the dopamine system.

Authors:  Michael A P Bloomfield; Abhishekh H Ashok; Nora D Volkow; Oliver D Howes
Journal:  Nature       Date:  2016-11-17       Impact factor: 49.962

6.  Thermal sensitivity in Tourette syndrome: preliminary report.

Authors:  L Scahill; P J Lombroso; G Mack; P J Van Wattum; H Zhang; A Vitale; J F Leckman
Journal:  Percept Mot Skills       Date:  2001-04

7.  Biogenic amine metabolism in Tourette syndrome.

Authors:  I J Butler; S H Koslow; W E Seifert; R M Caprioli; H S Singer
Journal:  Ann Neurol       Date:  1979-07       Impact factor: 10.422

8.  [Factors related to the short term remission of tics in children with Tourette syndrome].

Authors:  A García-Ribes; I Martí-Carrera; M J Martínez-González; C Garaizar; J M Prats-Viñas
Journal:  Rev Neurol       Date:  2003 Nov 16-30       Impact factor: 0.870

9.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

10.  Exacerbation of Gilles de la Tourette's syndrome associated with thermal stress: a family study.

Authors:  P J Lombroso; G Mack; L Scahill; R A King; J F Leckman
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.